Non-AFFF Firefighter Turnout Gear

This docket consolidates claims brought by firefighters alleging that PFAS chemicals present in their protective turnout gear, distinct from the separate and much larger litigation over PFAS-containing firefighting foam, caused cancer and other serious illnesses through prolonged occupational exposure, and that turnout-gear manufacturers marketed and sold the gear without adequately warning of these risks despite alleged knowledge of the danger. Centralized in the District of Minnesota in 2026, the docket is newly formed with 8 pending actions, and the JPML deliberately built the "Non-AFFF" distinction into the caption to keep this litigation separate from the established firefighting-foam MDL.

Despite its Sales Practices classification, this is fundamentally a personal-injury, occupational-exposure mass tort, closely analogous in claim structure to the much larger PFAS firefighting-foam litigation: firefighters with cancer diagnoses linked to alleged chemical exposure through protective equipment they were required to wear. For a funder, this means the applicable underwriting framework is a mass-tort injury and medical-lien model, not a consumer-labeling or commercial-purchaser theory, even though the docket sits under a Sales Practices heading in the JPML's own report.

Given the docket's very early stage, formed weeks before this report, and a recently added RICO theory alleging manufacturers coordinated to conceal known PFAS risks, this is a matter for careful, individualized underwriting focused on diagnosis-specific causation and documented occupational exposure history rather than a mature, standardized product. Criterica Capital's mass tort finance and medical-lien receivables products are the applicable frame here, with pricing that should account for the docket's nascent stage and the added complexity, and potential upside, of the RICO theory. A structure and litigation brief tracking this docket's early development is available.

Pre-settlement funding is a non-recourse purchase of a portion of the proceeds of a pending legal claim — not a loan. If the case does not result in a recovery, nothing is owed. Rates, fees, and repayment terms are disclosed in full in the funding agreement, which the applicant’s attorney reviews before signing. Availability and terms vary by state.